SCHEMBL13870825

SCHEMBL13870825

CCc1ccc2nc(-c3cc(C)cc(C)c3)c(OC)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PDE10A Q9Y233 7/20 0.39
▸ PDGFRB P09619 3/20 0.37
▸ PDGFRA P16234 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ PTK2B Q14289 1/20 0.37
▸ HTT P42858 1/20 0.35
▸ CRHR1 P34998 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870817 0.84 PDGFRB (0.44) MEN1KMT2AMAPTTDP1L3MBTL1
SCHEMBL13870804 0.81 MEN1 (0.41) MEN1KMT2AMAPTNPC1ALDH1A1
SCHEMBL13399629 0.80 PDGFRB (0.47) PDE10APDGFRBPDGFRAHTT
SCHEMBL13870821 0.78 RORC (0.40) KMT2APDGFRBPDGFRAHTT
SCHEMBL13870819 0.78 PSMB5 (0.37) MEN1KMT2AMAPTPDGFRBPDGFRA
SCHEMBL13870826 0.76 PDGFRB (0.39) MAPTL3MBTL1PDE10APDGFRBPDGFRA
SCHEMBL14500804 0.76 MEN1 (0.45) MEN1KMT2ATDP1L3MBTL1PDE10A
SCHEMBL13647152 0.75 CYP1A2 (0.42) MEN1KMT2AMAPTL3MBTL1PDE10A
SCHEMBL12313220 0.75 MAOA (0.41) MEN1KMT2AL3MBTL1PDGFRBPDGFRA
SCHEMBL13399622 0.74 PDGFRB (0.40) MAPTL3MBTL1PDGFRBPDGFRANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 MEN1 1373/4885KMT2A 2208/4885MAPT 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback